International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6
View All Articles in Issue

Page(s): 486

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, gabapentin, gabapentinoid, voltage-dependent calcium channel inhibitor, anticonvulsant agent, seizure disorder, epilepsy, headache, hiccups, neurological disorders, neuromuscular disorders, diabetic neuropathy, postoperative pain, chronic pain, neuropathic pain

Related Categories: EXCIPIENTS, FORMULATIONS, PAIN MANAGEMENT, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 486
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Stability of Gabapentin in SyrSpend SF Sorenson Bridget, Voudrie Mark A II, Gehrig Dan	Jul/Aug 2012 Pg. 347-349
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 488
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Allen Loyd V Jr	Nov/Dec 2019 Pg. 494
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Williams LaVonn A, Fokken Dawn	Sep/Oct 2009 Pg. 386-389
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 235
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 502
Methylprednisolone 4-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 340
Gabapentin 100-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 456
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 148
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Shakshuki Ayah, Agu Remigius U	Nov/Dec 2019 Pg. 496-503
Treating Inner Ear Disorders with Intratympanic Drug Administration McElhiney Linda F	Jul/Aug 2011 Pg. 302-307
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Attention Deficit Hyperactivity Disorder Allen Loyd V Jr	Mar/Apr 1997 Pg. 87-89
Return to Top